Long intergenic non-protein coding RNA 244 (LINC00244)

Long intergenic non-protein coding RNA 244 (LINC00244) is a long non-coding RNA (lncRNA), classified as a lincRNA, that does not code for protein. It is most studied in the context of hepatocellular carcinoma, where it acts as a tumor suppressor by downregulating PD-L1 expression, thereby inhibiting cell proliferation, metastasis, and the epithelial-mesenchymal transition (EMT) pathway. This negative regulation of PD-L1 predicts a good prognosis in HCC patients and suggests LINC00244 as a potential therapeutic target and prognostic biomarker in cancer. It is not known to interact with any drugs directly, nor is it a classical druggable protein target such as a receptor or enzyme, but its regulatory effects on gene expression and tumor immunity are clinically relevant[1][2][5][9]. Additional notes: - LINC00244 is not a protein, receptor, enzyme, or classical drug target, but qualifies as a *therapeutic target* in the sense applied to regulatory RNAs due to its functional links to cancer progression and immune modulation[2]. - No known small molecules or drugs directly target LINC00244, but it could be manipulated using RNA-targeting strategies (e.g., siRNAs, antisense oligonucleotides)[2]. - The primary disease context is *hepatocellular carcinoma*; other roles remain to be validated.

Other names

C7orf4NCRNA00244LINC00244